Skip to main content
OpenTrials
Completed

NCT Number: NCT03976141

New Topographic Classification of Knee Bone Marrow Lesions

the investigator are studying a new topographic classification of bone marrow lesion in the knee and validating it.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

2) 1° Clinica Ortopedica, ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO

Milan, 20122, Italy

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age over 18 with mri with lesion consent given

Exclusion criteria

  • under mri previous surgery tumors no consent

Treatment and study plan

MRI

Diagnostic Test

knee mri

Primary outcomes

  1. The researchers will calculate the prevalence of BMLs in knee MRI and calculate the intra-observer and inter-observer reliability of the new classification proposed.

    Time frame: The lesions will be evaluated on knee MRI performed in the period between January 2017 to December 2018

    This study proposes a topographic classification for knee BMLs consisting in 5 different types of lesions. the classification proposed will be validated by 3 independent researchers.

Sponsors and collaborators

Lead sponsor

University of Milan

Other

Registry information

Official study title

Validation of a New Topographic Classification of Bone Marrow Lesions of the Knee

Acronym: ncbe

Important dates

Study start
2019
Primary completion
2019
Study completion
2020
First posted
Jun 5, 2019
Registry last updated
Nov 16, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.